<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="141144">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01263522</url>
  </required_header>
  <id_info>
    <org_study_id>SAusE2011</org_study_id>
    <nct_id>NCT01263522</nct_id>
  </id_info>
  <brief_title>Optimization of Preventive Effects of Physical Training</brief_title>
  <acronym>SAusE</acronym>
  <official_title>Optimization of Preventive Effects of Physical Training &quot;Saarl채ndische Ausdauer-Etappe (SAusE)&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Saarland University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Saarland University</source>
  <brief_summary>
    <textblock>
      Health-promoting effects of physical exercise are well-investigated especially for endurance
      activities. However, for different individuals, positive effects have different sizes, even
      non-responders are observed. Other forms of training, such as strength training and interval
      training, are less well investigated. Therefore, a comparative longitudinal training study
      is warranted to examine differences of preventive effects (outcome measures: ergometric
      descriptors of physical performance, established risk factors and prognostic factors for
      cardiovascular diseases) of continuous endurance training, interval training and strength
      endurance training.

      In a second stage, the observed non-responders will perform a different type of training
      (cross-over). It is expected, that besides a comparative general efficacy evaluation of the
      three training types, improved recommendations for optimized individualization of training
      parameters can be formulated.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2010</start_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>VO2max</measure>
    <time_frame>6 months</time_frame>
    <description>determined during treadmill testing</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>resting heart rate</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>resting blood pressure</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood lipid profile</measure>
    <time_frame>6 months</time_frame>
    <description>ratio: total cholesterol/HDL-cholesterol</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Primary Prevention, Cardiovascular Risk Factor Management, Size of Response to Training</condition>
  <arm_group>
    <arm_group_label>Endurance training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>interval training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>strength endurance training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>different training programs</intervention_name>
    <description>two different endurance programs and one strength endurance program</description>
    <arm_group_label>Endurance training</arm_group_label>
    <arm_group_label>interval training</arm_group_label>
    <arm_group_label>strength endurance training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>control condition</intervention_name>
    <description>unchanged lifestyle</description>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: untrained, healthy and non-smoking men and women

        Exclusion Criteria: Contraindications for physical activity, BMI &gt; 30 kg/m2, resting blood
        pressure &gt; 160/100 mmHg, diabetes, total cholesterol &gt; 300 mg/dl, maximal oxygen uptake &gt;
        50 ml/min/kg for men and &gt; 45 ml/min/kg for women, respectively. Other complaints or
        diseases that might interfere with exercise training
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Institute of Sports and Preventive Medicine, Saarland University, Bldg. B 8-2, 66123 Saarbr체cken</name>
      <address>
        <city>Saarbr체cken</city>
        <state>Saarland</state>
        <zip>66123</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tim Meyer, Prof. Dr. med.</last_name>
      <phone>(0)681 - 302 3750</phone>
      <phone_ext>+49</phone_ext>
      <email>tim.meyer@mx.uni-saarland.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2010</verification_date>
  <lastchanged_date>December 17, 2010</lastchanged_date>
  <firstreceived_date>December 17, 2010</firstreceived_date>
  <responsible_party>
    <name_title>Institute of Sports and Preventive Medicine, Saarland University, Bldg. B 8-2, 66123 Saarbr체cken, Germany</name_title>
    <organization>Saarland University</organization>
  </responsible_party>
  <keyword>primary prevention</keyword>
  <keyword>endurance</keyword>
  <keyword>cardiovascular risk factors</keyword>
  <keyword>training</keyword>
  <keyword>exercise</keyword>
  <keyword>non-responder</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
